These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 9062387)

  • 1. MT1-MMP correlates with MMP-2 activation potential seen after epithelial to mesenchymal transition in human breast carcinoma cells.
    Pulyaeva H; Bueno J; Polette M; Birembaut P; Sato H; Seiki M; Thompson EW
    Clin Exp Metastasis; 1997 Mar; 15(2):111-20. PubMed ID: 9062387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implication of collagen type I-induced membrane-type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma.
    Gilles C; Polette M; Seiki M; Birembaut P; Thompson EW
    Lab Invest; 1997 May; 76(5):651-60. PubMed ID: 9166284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MT1-MMP and MMP-2 mRNA expression in human ovarian tumors: possible implications for the role of desmoplastic fibroblasts.
    Afzal S; Lalani EN; Poulsom R; Stubbs A; Rowlinson G; Sato H; Seiki M; Stamp GW
    Hum Pathol; 1998 Feb; 29(2):155-65. PubMed ID: 9490275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complex regulation of membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation by concanavalin A in MDA-MB-231 human breast cancer cells.
    Yu M; Sato H; Seiki M; Thompson EW
    Cancer Res; 1995 Aug; 55(15):3272-7. PubMed ID: 7614461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo MMP gene expression localisation by In Situ-RT-PCR in cell culture and paraffin embedded human breast cancer cell line xenografts.
    Haupt LM; Thompson EW; Trezise AE; Irving RE; Irving MG; Griffiths LR
    BMC Cancer; 2006 Jan; 6():18. PubMed ID: 16430785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of membrane-type matrix metalloproteinase 1 (MT1-MMP) expression in human fibroblasts by breast adenocarcinoma cells.
    Polette M; Gilles C; Marchand V; Seiki M; Tournier JM; Birembaut P
    Clin Exp Metastasis; 1997 Mar; 15(2):157-63. PubMed ID: 9062392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tyrosine phosphorylation mediates ConA-induced membrane type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in MDA-MB-231 human breast carcinoma cells.
    Yu M; Bowden ET; Sitlani J; Sato H; Seiki M; Mueller SC; Thompson EW
    Cancer Res; 1997 Nov; 57(22):5028-32. PubMed ID: 9371497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of MMP-2 activation potential with metastatic progression in human breast cancer cell lines independent of MMP-2 production.
    Azzam HS; Arand G; Lippman ME; Thompson EW
    J Natl Cancer Inst; 1993 Nov; 85(21):1758-64. PubMed ID: 8411260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of tissue inhibitor of metalloproteinases-2 (TIMP-2) in regulation of pro-gelatinase A activation catalyzed by membrane-type matrix metalloproteinase-1 (MT1-MMP) in human cancer cells.
    Shofuda K; Moriyama K; Nishihashi A; Higashi S; Mizushima H; Yasumitsu H; Miki K; Sato H; Seiki M; Miyazaki K
    J Biochem; 1998 Aug; 124(2):462-70. PubMed ID: 9685743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
    Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
    J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium influx inhibits MT1-MMP processing and blocks MMP-2 activation.
    Yu M; Sato H; Seiki M; Spiegel S; Thompson EW
    FEBS Lett; 1997 Aug; 412(3):568-72. PubMed ID: 9276468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shedding of membrane type 1 matrix metalloproteinase in a human breast carcinoma cell line.
    Harayama T; Ohuchi E; Aoki T; Sato H; Seiki M; Okada Y
    Jpn J Cancer Res; 1999 Sep; 90(9):942-50. PubMed ID: 10551322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of integrin alpha(v)beta(3) correlates with activation of membrane-type matrix metalloproteinase-1 (MT1-MMP) and matrix metalloproteinase-2 (MMP-2) in human melanoma cells in vitro and in vivo.
    Hofmann UB; Westphal JR; Van Kraats AA; Ruiter DJ; Van Muijen GN
    Int J Cancer; 2000 Jul; 87(1):12-9. PubMed ID: 10861447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines.
    Thompson EW; Paik S; Brünner N; Sommers CL; Zugmaier G; Clarke R; Shima TB; Torri J; Donahue S; Lippman ME
    J Cell Physiol; 1992 Mar; 150(3):534-44. PubMed ID: 1537883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion.
    Di Nezza LA; Misajon A; Zhang J; Jobling T; Quinn MA; Ostör AG; Nie G; Lopata A; Salamonsen LA
    Cancer; 2002 Mar; 94(5):1466-75. PubMed ID: 11920503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of matrix metalloproteinases (MMPs) in breast cancer xenografts: a major induction of stromal MMP-13.
    Lafleur MA; Drew AF; de Sousa EL; Blick T; Bills M; Walker EC; Williams ED; Waltham M; Thompson EW
    Int J Cancer; 2005 Apr; 114(4):544-54. PubMed ID: 15551360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SPARC/osteonectin induces matrix metalloproteinase 2 activation in human breast cancer cell lines.
    Gilles C; Bassuk JA; Pulyaeva H; Sage EH; Foidart JM; Thompson EW
    Cancer Res; 1998 Dec; 58(23):5529-36. PubMed ID: 9850090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological characterization of cell-surface and soluble forms of membrane type 1 matrix metalloproteinase in human breast cancer cells and in fibroblasts.
    Li H; Bauzon DE; Xu X; Tschesche H; Cao J; Sang QA
    Mol Carcinog; 1998 Jun; 22(2):84-94. PubMed ID: 9655252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas.
    Ueno H; Nakamura H; Inoue M; Imai K; Noguchi M; Sato H; Seiki M; Okada Y
    Cancer Res; 1997 May; 57(10):2055-60. PubMed ID: 9158005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro.
    Yamamoto M; Mohanam S; Sawaya R; Fuller GN; Seiki M; Sato H; Gokaslan ZL; Liotta LA; Nicolson GL; Rao JS
    Cancer Res; 1996 Jan; 56(2):384-92. PubMed ID: 8542596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.